Infectious cell culture systems of hepatitis C virus and their application in drug development
To date, the infectious cell culture systems of hepatitis C virus (HCV) representative of genotypes 1-3 have been developed with the aid of adaptive mutations identified from JFH1-based chimera viruses or replicons. Nevertheless, JFH1 is still the unique clone capable of spontaneous replication in l...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2015-11-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6938 |
id |
doaj-8751654e42d443798a9b4a2546be9ad5 |
---|---|
record_format |
Article |
spelling |
doaj-8751654e42d443798a9b4a2546be9ad52020-11-24T23:23:21ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562015-11-0131111825183010.3969/j.issn.1001-5256.2015.11.014Infectious cell culture systems of hepatitis C virus and their application in drug developmentLI Yiping0Institute of Human Virology, Zhongshan School of Medicine, and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou 510080, ChinaTo date, the infectious cell culture systems of hepatitis C virus (HCV) representative of genotypes 1-3 have been developed with the aid of adaptive mutations identified from JFH1-based chimera viruses or replicons. Nevertheless, JFH1 is still the unique clone capable of spontaneous replication in liver cell lines. It is an urgent need to develop a universal infectious cell culture system for any HCV clinical isolate. This article reviews the progress in HCV cell culture systems, existing infectious HCV clones, and permissive cell lines supporting HCV replication, as well as the application of HCV replication and infection model in drug development.http://www.lcgdbzz.org/qk_content.asp?id=6938 |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
LI Yiping |
spellingShingle |
LI Yiping Infectious cell culture systems of hepatitis C virus and their application in drug development Linchuang Gandanbing Zazhi |
author_facet |
LI Yiping |
author_sort |
LI Yiping |
title |
Infectious cell culture systems of hepatitis C virus and their application in drug development |
title_short |
Infectious cell culture systems of hepatitis C virus and their application in drug development |
title_full |
Infectious cell culture systems of hepatitis C virus and their application in drug development |
title_fullStr |
Infectious cell culture systems of hepatitis C virus and their application in drug development |
title_full_unstemmed |
Infectious cell culture systems of hepatitis C virus and their application in drug development |
title_sort |
infectious cell culture systems of hepatitis c virus and their application in drug development |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2015-11-01 |
description |
To date, the infectious cell culture systems of hepatitis C virus (HCV) representative of genotypes 1-3 have been developed with the aid of adaptive mutations identified from JFH1-based chimera viruses or replicons. Nevertheless, JFH1 is still the unique clone capable of spontaneous replication in liver cell lines. It is an urgent need to develop a universal infectious cell culture system for any HCV clinical isolate. This article reviews the progress in HCV cell culture systems, existing infectious HCV clones, and permissive cell lines supporting HCV replication, as well as the application of HCV replication and infection model in drug development. |
url |
http://www.lcgdbzz.org/qk_content.asp?id=6938 |
work_keys_str_mv |
AT liyiping infectiouscellculturesystemsofhepatitiscvirusandtheirapplicationindrugdevelopment |
_version_ |
1725564008857075712 |